Table 2:

Summary of patient diagnosesa

Group 1 (Gadobenate-Exposed)Group 2 (GBCA-Naïve Controls)
DiagnosisNo.DiagnosisNo.
T-cell non-Hodgkin lymphoma1Chronic recurrent osteomyelitis3
Hodgkin lymphoma3Pelvic trauma1
Coccygeal teratoma1Cystic fibrosis2
Nephroblastoma4DORV/VSD1
Neuroblastoma3Polycystic kidney disease1
Chronic recurrent osteomyelitis2Melanoma1
Hepatoblastoma2Non-Hodgkin lymphoma2
Mesoblastic nephroma1Skull base osteoid osteoma1
ALL1Germ cell tumor1
Paravertebral schwannoma1Polytrauma, knee distortion, ACL rupture1
Angioma of the spleen1Myocarditis2
Germ cell tumor2Hemophilia A1
Renal clear cell sarcoma1Blunt head trauma2
Ewing sarcoma3Osler disease1
Osteosarcoma2Multiple osteochondroma, whole-body staging1
Rhabdoid tumor of the kidney1Congenital aortic malformation, whole-body imaging1
Dermatofibrosarcoma1Persistent left superior vena cava, thoracic and head/neck imaging1
ARVD/ARVC1Hypertension work-up1
Hemangioendothelioma1
Renal leiomyosarcoma1
Focal nodular hyperplasia1
  • Note:—ALL indicates acute lymphoblastic leukemia; DORV, double outlet right ventricle; VSD, ventricula septal defect; ACL, anterior cruciate ligament; ARVD, arrhythmogenic right ventricular dysplasia; ARVC, arrhythmogenic right ventricular cardiomyopathy.

  • a Patients in group 1 underwent multiple gadobenate-enhanced MR imaging studies for therapy follow-up or remission control. Patients in group 2 underwent preliminary unenhanced imaging as part of the initial work-up at the first visit.